⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Glizigen-Viudid-External Anogenital Warts in Children and Adolescents

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Glizigen-Viudid-External Anogenital Warts in Children and Adolescents

Official Title: Efficacy of Glizigen-Viudid in the Treatment of External Anogenital Warts in Children and Adolescents.

Study ID: NCT01111344

Study Description

Brief Summary: The purpose of the study is to assess the efficacy of Glizigen and Viusid administration in the treatment of external anogenital warts in children and adolescents. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of persons to be recruited and randomized for the study is 76. Variables to be assessed will be: time to disappearance of lesions, reduction of the number of lesions and change in the aspect of lesions.

Detailed Description:

Eligibility

Minimum Age: 10 Years

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Pediatric Hospital "Dr. Juan Manuel Márquez"., Havana, , Cuba

Contact Details

Name: Edelisa Moredo Romo, MD

Affiliation: Pediatric Hospital "Dr. Juan Manuel Márquez.

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: